Aristippos Gennadios
Corporate Officer/Principal bei CATALENT, INC.
Vermögen: 5 Mio $ am 30.04.2024
Profil
Aristippos Gennadios has held various director and co-managing director positions in different branches of Catalent, including Catalent France Beinheim SA, Catalent Pharma Solutions Ltd., and Catalent Germany Eberbach GmbH.
He is currently the Group President-Pharma & Consumer Health at Catalent, Inc.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CATALENT INC
0,05% | 08.12.2023 | 96 496 ( 0,05% ) | 5 Mio $ | 30.04.2024 |
Aktive Positionen von Aristippos Gennadios
| Unternehmen | Position | Beginn |
|---|---|---|
| CATALENT, INC. | Corporate Officer/Principal | - |
Catalent Pharma Solutions Ltd.
 Catalent Pharma Solutions Ltd. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions Ltd. develops and markets drug delivery systems. The company is headquartered in Swindon, GB. | Direktor/Vorstandsmitglied | 08.12.2016 |
Catalent Germany Eberbach GmbH
 Catalent Germany Eberbach GmbH Household/Personal CareConsumer Non-Durables Part of Catalent, Inc., Catalent Germany Eberbach GmbH is a company that manufactures and supplies soft gel and pharmaceutical products. The company is based in Eberbach, Germany. The CEOs are Steven Lawrence Fasman, Aristippos Gennadios, Raoul Bernhardt. The company was founded in 2012. | Vorstandsvorsitzender | - |
Catalent France Beinheim SA
 Catalent France Beinheim SA Pharmaceuticals: MajorHealth Technology Catalent France Beinheim SA is engaged in softgel development and manufacturing operations. It offers formulation development and manufacturing services for controlled substances, highly potent compounds, and hormones. The firm’s technologies include optiform® solution suite, optigel™ bio, and rp scherer softgel technology. The company was founded on May 3, 1965 and is headquartered in Beinheim, France. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CATALENT, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Catalent France Beinheim SA
Catalent France Beinheim SA Pharmaceuticals: MajorHealth Technology Catalent France Beinheim SA is engaged in softgel development and manufacturing operations. It offers formulation development and manufacturing services for controlled substances, highly potent compounds, and hormones. The firm’s technologies include optiform® solution suite, optigel™ bio, and rp scherer softgel technology. The company was founded on May 3, 1965 and is headquartered in Beinheim, France. | Health Technology |
Catalent Pharma Solutions Ltd.
Catalent Pharma Solutions Ltd. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions Ltd. develops and markets drug delivery systems. The company is headquartered in Swindon, GB. | Health Technology |
Catalent Germany Eberbach GmbH
Catalent Germany Eberbach GmbH Household/Personal CareConsumer Non-Durables Part of Catalent, Inc., Catalent Germany Eberbach GmbH is a company that manufactures and supplies soft gel and pharmaceutical products. The company is based in Eberbach, Germany. The CEOs are Steven Lawrence Fasman, Aristippos Gennadios, Raoul Bernhardt. The company was founded in 2012. | Consumer Non-Durables |
